Prosecution Insights
Last updated: April 19, 2026

BETA PHARMA, INC.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18547052 PYRIDOPYRIMIDINE DERIVATIVES AS KRAS INHIBITORS SEITZ, ANTHONY JOSEPH 1629 Non-Final OA Aug 18, 2023
17426296 2H-INDAZOLE DERIVATIVES AS THERAPEUTIC AGENTS FOR BRAIN CANCERS AND BRAIN METASTASES LEE, CHIHYI NMN 1628 Final Rejection Jul 28, 2021

Managing BETA PHARMA, INC.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month